Novavax
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novavax and other ETFs, options, and stocks.About NVAX
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines.
NVAX Key Statistics
NVAX News
Moderna rises on FDA Covid vaccine guidance that doesn't destroy their core business Moderna jumped on Tuesday after the Food and Drug Administration approved...
Novavax, Inc. ( ) shareholders are no doubt pleased to see that the share price has bounced 29% in the last month, although it is still struggling to make up re...
Bank of America Securities analyst Alec Stranahan reiterated a Hold rating on Novavax (NVAX – Research Report) today and set a price target of $10.00. Confiden...
Analyst ratings
57%
of 7 ratingsMore NVAX News
The FDA approved the biologics license application for Nuvaxovid for active immunization to prevent coronavirus disease 2019 caused by severe acute respiratory...
Novavax Inc. NVAX has received limited approval from the U.S. Food and Drug Administration for its COVID-19 vaccine, Nuvaxovid, marking a regulatory milestone a...
U.S. stocks were lower, with the Nasdaq Composite falling around 50 points on Monday. Shares of CI&T Inc. CINT rose sharply during Monday's session. JP Morgan...
Novavax climbs after its Covid jab gets FDA approval American vaccine maker Novavax rose more than 20% in early trading on Monday after it announced that the F...
Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market...
07:00 EDT Novavax (NVAX) jumps 15% to $7.73 after FDA approves COVID vaccine Published first on TheFly – the ultimate source for real-time, market-moving break...
Shares of Novavax, Inc NVAX rose sharply in today's pre-market after the FDA gave its conditional approval to its COVID-19 vaccine, targeting specific populatio...
